Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q1 2026 Earnings Call Transcript May 6, 2026
Zevra Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.6, expectations were $0.06.
Nichol L. Ochsner: Good afternoon, and thank you for joining Zevra Therapeutics, Inc.’s First Quarter 2026 Financial Results and Corporate Update Conference Call. Today’s call is being recorded and will be available via the Investor Relations section of the company’s website later today. The host for today’s...
